Marquette Asset Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
WT
BHIA
NONA
SIM
Marquette Asset Management's EW Position: Q2 2026 in Review
Marquette Asset Management reduced its Edwards Lifesciences (EW) stake by 43% in Q2 2026, selling an estimated $5.11K and leaving 80 shares worth $7.24K. The position accounts for ﹤0.01% of the portfolio, ranked #371.
Marquette Asset Management first reported a position in EW in Q1 2019 and has held it in 20 quarters since. The position peaked at $351K in Q4 2021. 561 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- Marquette Asset Management held 80 shares of Edwards Lifesciences worth $7.24K as of Q2 2026.
- Marquette Asset Management sold 61 Edwards Lifesciences shares in Q2 2026, an estimated $5.11K.
- Edwards Lifesciences made up ﹤0.01% of Marquette Asset Management's portfolio in Q2 2026, its #371 holding.
- Marquette Asset Management first reported a position in Edwards Lifesciences in Q1 2019 and has held it in 20 quarters since.
- Marquette Asset Management's Edwards Lifesciences position peaked at $351K in Q4 2021.
- 561 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on Marquette Asset Management's 13F filing for Q2 2026, filed 9 Jul 2026.